Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven brokerages that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating, three have assigned a buy rating and two have given a strong buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $22.70.
SENS has been the subject of a number of recent research reports. Weiss Ratings began coverage on shares of Senseonics Holdings, Inc. Common Stock in a research note on Tuesday, February 17th. They issued a “sell (d-)” rating for the company. TD Cowen reaffirmed a “buy” rating on shares of Senseonics Holdings, Inc. Common Stock in a research report on Thursday, January 8th. Finally, Stifel Nicolaus set a $9.00 price target on Senseonics Holdings, Inc. Common Stock in a report on Tuesday, March 3rd.
View Our Latest Stock Analysis on SENS
Senseonics Holdings, Inc. Common Stock Stock Up 0.7%
Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Goldman Sachs Group Inc. boosted its holdings in shares of Senseonics Holdings, Inc. Common Stock by 26.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 612,534 shares of the company’s stock valued at $402,000 after buying an additional 127,086 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Senseonics Holdings, Inc. Common Stock by 26.6% during the 2nd quarter. Geode Capital Management LLC now owns 8,701,129 shares of the company’s stock worth $4,147,000 after acquiring an additional 1,828,302 shares in the last quarter. Sio Capital Management LLC bought a new position in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth approximately $2,312,000. JBR Co Financial Management Inc purchased a new stake in Senseonics Holdings, Inc. Common Stock during the second quarter valued at approximately $65,000. Finally, Walleye Capital LLC purchased a new stake in Senseonics Holdings, Inc. Common Stock during the second quarter valued at approximately $539,000. Hedge funds and other institutional investors own 12.36% of the company’s stock.
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.
Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.
See Also
- Five stocks we like better than Senseonics Holdings, Inc. Common Stock
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Receive News & Ratings for Senseonics Holdings Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
